Safety, tolerability and immunogenicity of low dose Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B

被引：7

作者：

Anderson, EL ^{[1
]}

Frey, S ^{[1
]}

Geldmacher, K ^{[1
]}

Radley, D ^{[1
]}

Lee, A ^{[1
]}

Donnelly, J ^{[1
]}

Mendelman, PM ^{[1
]}

Dargan, JM ^{[1
]}

Kaplan, KM ^{[1
]}

机构：

[1] Merck & Co Inc, West Point, PA 19486 USA

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2002年 / 21卷 / 04期

关键词：

Haemophilus influenzae type b disease; Haemophilus influenzae type b conjugate vaccine; conjugate vaccines; anti-PRP; PRP-OMPC;

D O I：

10.1097/00006454-200204000-00019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Infants vaccinated with three doses followed by a booster of either 1.0 mug of Haemophilus influenzae type b conjugated to the outer membrane protein complex of Neisseria meningitidis group B or H. influenzae 10-mug oligosaccharide vaccine conjugated to 25 mug mutant toxin (CRM197) isolated from Corynebacterium diphtheriae had protective anti-polyribosylribitol phosphate concentrations.

引用

收藏

页码：350 / 352

页数：3

相关论文

共 17 条

[1] IGG1, IGG2 AND IGM RESPONSES TO 2 HAEMOPHILUS-INFLUENZAE TYPE-B CONJUGATE VACCINES IN YOUNG INFANTS [J].

AMBROSINO, DM ;

SOOD, SK ;

LEE, MC ;

CHEN, D ;

COLLARD, HR ;

BOLON, DL ;

JOHNSON, C ;

DAUM, RS .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (10) :855-859

[2] Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants [J].

Anderson, EL ;

Kennedy, DJ ;

Geldmacher, KM ;

Donnelly, J ;

Mendelman, PM .

JOURNAL OF PEDIATRICS, 1996, 128 (05) :649-653

[3] INTERCHANGEABILITY OF CONJUGATED HAEMOPHILUS-INFLUENZAE TYPE-B VACCINES IN INFANTS [J].

ANDERSON, EL ;

DECKER, MD ;

ENGLUND, JA ;

EDWARDS, KM ;

ANDERSON, P ;

MCINNES, P ;

BELSHE, RB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (11) :849-853

[4] Haemophilus influenzae invasive disease in the United States, 1994-1995: Near disappearance of a vaccine-preventable childhood disease [J].

Bisgard, KM ;

Kao, A ;

Leake, J ;

Strebel, PM ;

Perkins, BA ;

Wharton, M .

EMERGING INFECTIOUS DISEASES, 1998, 4 (02) :229-237

[5] EFFICACY IN INFANCY OF OLIGOSACCHARIDE CONJUGATE HAEMOPHILUS-INFLUENZAE TYPE-B (HBOC) VACCINE IN A UNITED-STATES POPULATION OF 61080 CHILDREN [J].

BLACK, SB ;

SHINEFIELD, HR ;

FIREMAN, B ;

HIATT, R ;

POLEN, M ;

VITTINGHOFF, E .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (02) :97-104

[6]

*CDC, 2001, MMWR-MORBID MORTAL W, V48, P1

[7] COMPARATIVE TRIAL IN INFANTS OF 4 CONJUGATE HAEMOPHILUS-INFLUENZAE TYPE-B VACCINES [J].

DECKER, MD ;

EDWARDS, KM ;

BRADLEY, R ;

PALMER, P .

JOURNAL OF PEDIATRICS, 1992, 120 (02) :184-189

[8] Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine [J].

Fernández, J ;

Balter, S ;

Feris, J ;

Gómez, E ;

Garib, Z ;

Castellanos, PL ;

Sánchez, J ;

Romero-Steiner, S ;

Levine, OS .

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2000, 62 (04) :485-490

[9]

HUSSEY G, 1996, 7 INT C INF DIS HONG, P277

[10]

KAYHTY H, 1983, J INFECT DIS, V147, P1100